Periodic Reporting for period 1 - ParSyncR (Improving quality of life of Parkinson’s disease patients by Quantitative Cognitive Testing)

Parkinson’s Disease is the second most common neurodegenerative disease, affecting over 6 million people – a figure expected to grow rapidly with an aging population. While it is generally considered a motor disease, over 90% of all patients develop cognitive symptoms over...